Update 2021: Management of Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Update 2021: Management of Small Cell Lung Cancer

Published:2021-11-10 Issue:6 Volume:199 Page:579-587
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Tariq Sara,Kim So Yeon,Monteiro de Oliveira Novaes Jose,Cheng Haiying^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00408-021-00486-y.pdf

Reference62 articles.

1. Institute NC (2020) Cancer of the lung and bronchus (invasive). SEER database web site. https://seer.cancer.gov/csr/1975_2017/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.28. Accessed 12 Apr 2021

2. Gazdar AF, Bunn PA, Minna JD (2017) Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer 17(12):725–737

3. Cardona AF, Rojas L, Zatarain-Barrón ZL et al (2019) Multigene mutation profiling and clinical characteristics of small-cell lung cancer in never-smokers vs. heavy smokers (Geno1.3-CLICaP). Front Oncol. https://doi.org/10.3389/fonc.2019.00254

4. Zhong J, Zheng Q, An T et al (2019) Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: a competing risk analysis. Thorac Cancer 10(9):1788–1797

5. Horn L, Mansfield AS, Szczęsna A et al (2018) First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 379(23):2220–2229

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer;Respiratory Medicine and Research;2024-11

2. Anxiety and Depression in Advanced and Metastatic Lung Cancer Patients—Correlations with Performance Status and Type of Treatment;Medicina;2024-09-09

3. Neural network models based on clinical characteristics for predicting immunotherapy efficacy in small cell lung cancer;Malignancy Spectrum;2024-08-04

4. Selagibenzophenone B and Its Derivatives: SelB-1, a Dual Topoisomerase I/II Inhibitor Identified through In Vitro and In Silico Analyses;ACS Bio & Med Chem Au;2024-07-26

5. A review of trilaciclib, a first-in-class cyclin-dependent kinase 4/6 inhibitor, for the management of metastatic small-cell lung cancer;Medicinal Chemistry Research;2024-07-26